Increasing lines of research have demonstrated that LPCAT3 plays important roles in the occurrence and development of many diseases, such as atherosclerosis, intestinal tumors, and nonalcoholic steatohepatitis (NASH). Here, LPCAT3 is linked to metabolic dysfunction-associated steatohepatitis.